These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 18843027

  • 1. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
    Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, Hernandez-Avila M.
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
    [Abstract] [Full Text] [Related]

  • 2. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    Sepúlveda C, Prado R.
    Cancer Detect Prev; 2005 Oct; 29(5):405-11. PubMed ID: 16188399
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M, Hoque E, Kader SB.
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [Abstract] [Full Text] [Related]

  • 4. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M, Daltveit AK, Thoresen SO, Nygård JF.
    BMC Health Serv Res; 2007 Jan 23; 7():10. PubMed ID: 17244348
    [Abstract] [Full Text] [Related]

  • 5. Organisation of cervical cytology screening in Croatia: past, present and future.
    Pajtler M, Audy-Jurković S, Kardum-Skelin I, Mahovlić V, Mozetic-Vrdoljak D, Ovanin-Rakić A.
    Coll Antropol; 2007 Apr 23; 31 Suppl 2():47-54. PubMed ID: 17598505
    [Abstract] [Full Text] [Related]

  • 6. Validity of self-reported Pap smear history in Norwegian women.
    Klungsøyr O, Nygård M, Skare G, Eriksen T, Nygård JF.
    J Med Screen; 2009 Apr 23; 16(2):91-7. PubMed ID: 19564522
    [Abstract] [Full Text] [Related]

  • 7. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 8. Factors associated with non-use of Pap test. A population survey.
    Hernández-Hernández DM, García-Elizondo MR, Ornelas-Bernál L, Hernández-Alemán F, González-Lira G, Martínez-García MC.
    Arch Med Res; 1998 May 07; 29(3):263-70. PubMed ID: 9775462
    [Abstract] [Full Text] [Related]

  • 9. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA.
    Cancer; 2000 May 15; 88(10):2283-9. PubMed ID: 10820350
    [Abstract] [Full Text] [Related]

  • 10. Cervical cancer screening among Latinas recently immigrated to the United States.
    Fernández-Esquer ME, Cardenas-Turanzas M.
    Prev Med; 2004 May 15; 38(5):529-35. PubMed ID: 15066355
    [Abstract] [Full Text] [Related]

  • 11. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
    Arrossi S, Ramos S, Paolino M, Sankaranarayanan R.
    Reprod Health Matters; 2008 Nov 15; 16(32):50-8. PubMed ID: 19027622
    [Abstract] [Full Text] [Related]

  • 12. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R, Morrell S, Mamoon H, Wain G, Ross J.
    Cancer Causes Control; 2006 Apr 15; 17(3):299-306. PubMed ID: 16489537
    [Abstract] [Full Text] [Related]

  • 13. Effect of organized screening on incidence and mortality of cervical cancer in Denmark.
    Lynge E, Madsen M, Engholm G.
    Cancer Res; 1989 Apr 15; 49(8):2157-60. PubMed ID: 2702657
    [Abstract] [Full Text] [Related]

  • 14. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
    Sasagawa T.
    Rinsho Byori; 2009 Sep 15; 57(9):905-12. PubMed ID: 19860220
    [Abstract] [Full Text] [Related]

  • 15. Cervical cytology in vulnerable pregnant women.
    Loomis DM, Pastore PA, Rejman K, Gutierrez KL, Bethea B.
    J Am Acad Nurse Pract; 2009 May 15; 21(5):287-94. PubMed ID: 19432913
    [Abstract] [Full Text] [Related]

  • 16. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A, Ozkilinc G, Guler A, Oztop I.
    Eur J Cancer Care (Engl); 2008 May 15; 17(3):278-84. PubMed ID: 18419631
    [Abstract] [Full Text] [Related]

  • 17. Current techniques in screening for cervical cancer in Spain: updated recommendations.
    Puig-Tintoré LM, Torné A, Alonso I.
    Gynecol Oncol; 2008 Sep 15; 110(3 Suppl 2):S8-S10. PubMed ID: 18606440
    [Abstract] [Full Text] [Related]

  • 18. Educational level and cervical cancer screening programs in a Venezuelan urban area.
    Núñez-Troconis J, Velásquez J, Mindiola R, Munroe D.
    Invest Clin; 2008 Sep 15; 49(3):331-9. PubMed ID: 18846774
    [Abstract] [Full Text] [Related]

  • 19. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
    Igidbashian S, Maggioni A, Casadio C, Boveri S, Cristoforoni P, Sideri M.
    Vaccine; 2009 May 29; 27 Suppl 1():A34-8. PubMed ID: 19480959
    [Abstract] [Full Text] [Related]

  • 20. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
    Hølund B, Grinsted P.
    Ugeskr Laeger; 2006 May 29; 168(22):2163-6. PubMed ID: 16768956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.